Palliative Hypofractionated Radiotherapy in Advanced Incurable Breast Cancer (HYPORT)
Hypofractionated Radiotherapy Schedule of 35 Gray in 10 Fractions in Advanced Incurable Breast Cancer: A Prospective Phase I/II Study
Sponsor: Tata Medical Center
Listed as NCT03511781, this NA trial focuses on Carcinoma Breast Stage IV and remains completed. Sponsored by Tata Medical Center, it has been updated 8 times since 2015, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2022 — Jul 2024 [monthly]
Completed NA
Status: Active Not Recruiting → Completed
-
Jan 2021 — Jan 2022 [monthly]
Active Not Recruiting NA
-
Feb 2020 — Jan 2021 [monthly]
Active Not Recruiting NA
▶ Show 3 earlier versions
-
Jul 2018 — Feb 2020 [monthly]
Active Not Recruiting NA
-
Jun 2018 — Jul 2018 [monthly]
Active Not Recruiting NA
-
May 2018 — Jun 2018 [monthly]
Active Not Recruiting NA
First recorded
Sep 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Tata Medical Center
For direct contact, visit the study record on ClinicalTrials.gov .